ArticleImmunogenetics2024

Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization.

Jiaxin Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.